Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 6—June 2003
Dispatch

Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea

Margaret E. McCusker*, Anthony D. Harris†, Eli N. Perencevich†, and Mary-Claire Roghmann*†Comments to Author 
Author affiliations: *University of Maryland, Baltimore, Maryland, USA; †Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA

Main Article

Table 3

Multivariable model of risk factors for Clostridium difficile–associated diarrhea in cases (n=30) versus controls (n=60), controlling for days at risk

Risk factor Odds ratio 95% confidence interval
Fluoroquinolones
 12.7
 2.6 to 61.6
       Cephalosporins
 0.4
 0.1 to 1.5
       Clindamycin 2.2 0.5 to 9.1

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external